Demographics of control and sarcoidosis groups

Control subjectsSubjects with sarcoidosisp-value
Total subjects n2714
Age years, median53.060.50.3355
Sex n0.7337
Race n0.0005
Body mass index kg·m−2, median26.131.840.0319
Days between vaccine dose, mean21.320.90.0793
Days between 1st vaccine and V2D7, mean6.96.90.4939
Days between 1st vaccine and M6, mean180.9192.60.0575

V2D7: 7 days after vaccine dose 2 (4 weeks after 1st dose); M6: month 6 time point.